• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • COVID-19

    World Bank to finance vaccine production in Africa, increase fund to $20B

    The World Bank and three governments are investing in a South African manufacturer to boost production of COVID-19 vaccines on the African continent.

    By Shabtai Gold // 01 July 2021
    World Bank President David Malpass. Photo by: Kim Haughton / IMF photo / CC BY-NC-ND

    The World Bank and three governments are investing in a South African vaccine manufacturer in an effort to boost production of COVID-19 vaccines on the African continent.

    Bank President David Malpass said there is “surging” demand for vaccines from lower-income nations. “We want countries to know the financing is available,” he said.

    Sign up for Devex CheckUp
    The must-read weekly newsletter for exclusive global health news and insider insights.

    The €600 million funding package for Aspen Pharmacare, which is Africa’s largest pharmaceutical company and is based in Durban, comes from the International Finance Corp. — the World Bank’s private sector arm — in cooperation with the U.S. International Development Finance Corp.; DEG, the German development finance institution; and Proparco, a subsidiary of France’s Agence Française de Développement.

    The fund includes money for the entire vaccine supply chain. Aspen aims to produce more than 500 million doses of the Johnson & Johnson single-dose vaccine by the end of 2022.

    The World Bank also said Wednesday that it will increase its funding aimed at supporting the global vaccine rollout from $12 billion to $20 billion.

    Why it matters: Lower-income countries account for a fraction of the roughly 3 billion COVID-19 vaccines doses administered globally. While the U.S. has delivered some 98 doses per 100 people, Nigeria — Africa’s most populous country — has delivered just 1.7 per 100.

    So far, 51 countries have received World Bank assistance on vaccines, worth upwards of $4 billion. There is growing recognition that Africa needs more domestic pharma production, with most sub-Saharan nations importing over 70% of the drugs they consume.

    What’s next: Malpass also called on countries in the G-20 group of nations to share more vaccine doses and commit to the pledge of vaccinating 40% of the global population by the end of this year and 60% in 2022. Finance ministers from the group of major economies are set to meet in July.

    • Global Health
    • Private Sector
    • Banking & Finance
    • World Bank
    • South Africa
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Shabtai Gold

      Shabtai Gold

      Shabtai Gold is a Senior Reporter based in Washington. He covers multilateral development banks, with a focus on the World Bank, along with trends in development finance. Prior to Devex, he worked for the German Press Agency, dpa, for more than a decade, with stints in Africa, Europe, and the Middle East, before relocating to Washington to cover politics and business.

    Search for articles

    Related Stories

    Global HealthAfrica’s vaccine manufacturing ambitions get a boost with new partnerships

    Africa’s vaccine manufacturing ambitions get a boost with new partnerships

    Global healthHow Asia-Pacific can boost vaccine access in the next pandemic

    How Asia-Pacific can boost vaccine access in the next pandemic

    Global HealthThe urgent need to rethink Africa's health financing

    The urgent need to rethink Africa's health financing

    Global healthOpinion: Trump aid shock underscores need for more made-in-Africa medicine

    Opinion: Trump aid shock underscores need for more made-in-Africa medicine

    Most Read

    • 1
      How to use law to strengthen public health advocacy
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      House cuts US global education funding 20%, spares multilateral partners
    • 4
      The power of diagnostics to improve mental health
    • 5
      Opinion: The pursuit of remission — from possibility to priority
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement